Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions.
We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease.
"synopsis" may belong to another edition of this title.
`Thyroid Cancer, edited by James A. Fagin, comprehensively discusses all the important issues related to this subject. This book will appeal to a broad spectrm of researchers and practitioners, including endocrinologists, nuclear-medicine specialists, and oncologists. As an endocrinologist facing the management of thyroid cancer daily, I enjoyed reading this book and learned from it.'
Furio Pacini in The New England Journal of Medicine, 341:26 (1999)
This text provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. The material should be of interest to scholars in the field, and the contributors have striven to make it of practical use to physicians who treat patients with thyroid cancer.
"About this title" may belong to another edition of this title.
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-118421
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In English. Seller Inventory # ria9780792383260_new
Quantity: Over 20 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. Offers information on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. This title is of interest to scholars in the field, as well as to physicians who treat patients with thyroid disease. Editor(s): Fagin, James A. Series: Endocrine Updates. Num Pages: 372 pages, biography. BIC Classification: MJCL; MJG. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 22. Weight in Grams: 1560. . 1998. Hardback. . . . . Seller Inventory # V9780792383260
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived. Seller Inventory # 458442761
Quantity: Over 20 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. Offers information on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. This title is of interest to scholars in the field, as well as to physicians who treat patients with thyroid disease. Editor(s): Fagin, James A. Series: Endocrine Updates. Num Pages: 372 pages, biography. BIC Classification: MJCL; MJG. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 22. Weight in Grams: 1560. . 1998. Hardback. . . . . Books ship from the US and Ireland. Seller Inventory # V9780792383260
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease. Seller Inventory # 9780792383260